nutrients-logo

Journal Browser

Journal Browser

Nutritional Interventions to Shift the Gut Microbiome for Gut and Systemic Health

A special issue of Nutrients (ISSN 2072-6643). This special issue belongs to the section "Nutrition and Metabolism".

Deadline for manuscript submissions: closed (31 August 2021) | Viewed by 23083

Special Issue Editors


E-Mail Website
Guest Editor
College of Agriculture and Applied Sciences, Department of Animal, Dairy and Veterinary Sciences, Utah State University, 4800 Old Main Hill, Logan, UT 84322, USA
Interests: food bioactives; cancer prevention; colorectal cancer; western-type diet; inflammation; gene regulation; epigenetics

E-Mail Website
Guest Editor
College of Agriculture and Applied Sciences, Department of Nutrition, Dietetics and Food Sciences, Utah State University, 8700 Old Main Hill, Logan, UT 84322, USA
Interests: gut microbiome; Western diet; chronic disease; gut health

Special Issue Information

Dear Colleagues,

In this Special Issue of Nutrients, we wish to bring together high-quality papers focusing on the role of the microbiome in mediating the beneficial health effects of nutritional interventions. Such interventions may include 1) broad shifts in the basal diet or studies investigating different nutritional patterns (e.g., the Mediterranean diet or Western-type diet), 2) interventions with functional whole foods or food extracts, or 3) interventions with individual or combined bioactive food components or specific vitamins or minerals. 

For this Special Issue, we are particularly interested in the intersection of these diets or dietary components with the composition or activity of the gut microbiome and potential beneficial effects for health. Papers exploring this topic may focus on many aspects of gut and/or systemic health, including inflammatory bowel disease, colorectal cancer, colitis-associated colorectal cancer, gut leakiness, metabolic syndrome, obesity, diabetes, cardiovascular disease, systemic inflammation, and other immune disorders. 

Preclinical studies employing animal models are welcome, as are reports of clinical studies in humans. We also welcome different types of manuscript submissions, including original research articles and up-to-date critical review papers.

Investigations of the impact of various diets or bioactives on the gut microbiome have been of great interest over the past decade, although researchers have identified challenges in study design and data analyses that need careful attention as this field continues to mature. In this Special Issue, we are particularly interested in papers that explore the dynamic changes in the population and/or metabolic activity of gut microbes. Additionally, we encourage the submission of papers with robust experiment design and data analysis strategies that consider the particular complexities of studies exploring the intersection of diet, the microbiome, and gut/systemic health, such as microbial community sharing among co-housed animals. We also encourage studies that carefully consider the contribution of the basal/control diet (e.g., chow versus semi-purified diets with different fiber sources or amounts) in experiments involving interventions with functional foods or dietary bioactives. Lastly, we encourage papers that employ -omics approaches to characterize microbiota populations and/or their metabolites and request that underlying data be provided with the manuscript for full transparency and further exploration by the scientific community.

Dr. Abby D. Benninghoff
Assoc. Prof. Korry Hintze
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nutrients is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Gut microbiome
  • Microbiota
  • Functional foods
  • Food bioactives
  • Bioactive nutrients
  • Gut health
  • Inflammation
  • Colorectal cancer
  • Inflammatory bowel disease
  • Chronic disease

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (4 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

21 pages, 12006 KiB  
Article
The Western Dietary Pattern Combined with Vancomycin-Mediated Changes to the Gut Microbiome Exacerbates Colitis Severity and Colon Tumorigenesis
by Niklas D. Aardema, Daphne M. Rodriguez, Arnaud J. Van Wettere, Abby D. Benninghoff and Korry J. Hintze
Nutrients 2021, 13(3), 881; https://doi.org/10.3390/nu13030881 - 9 Mar 2021
Cited by 8 | Viewed by 3456
Abstract
Previous work by our group using a mouse model of inflammation-associated colorectal cancer (CAC) showed that the total Western diet (TWD) promoted colon tumor development. Others have also shown that vancomycin-mediated changes to the gut microbiome increased colorectal cancer (CRC). Therefore, the objective [...] Read more.
Previous work by our group using a mouse model of inflammation-associated colorectal cancer (CAC) showed that the total Western diet (TWD) promoted colon tumor development. Others have also shown that vancomycin-mediated changes to the gut microbiome increased colorectal cancer (CRC). Therefore, the objective of this study was to determine the impact of vancomycin on colon tumorigenesis in the context of a standard mouse diet or the TWD. A 2 × 2 factorial design was used, in which C57Bl/6J mice were fed either the standard AIN93G diet or TWD and with vancomycin in the drinking water or not. While both the TWD and vancomycin treatments independently increased parameters associated with gut inflammation and tumorigenesis compared to AIN93G and plain water controls, mice fed the TWD and treated with vancomycin had significantly increased tumor multiplicity and burden relative to all other treatments. Vancomycin treatment significantly decreased alpha diversity and changed the abundance of several taxa at the phylum, family, and genus levels. Conversely, basal diet had relatively minor effects on the gut microbiome composition. These results support our previous research that the TWD promotes colon tumorigenesis and suggest that vancomycin-induced changes to the gut microbiome are associated with higher tumor rates. Full article
Show Figures

Figure 1

Review

Jump to: Research

22 pages, 1567 KiB  
Review
Nutritional Therapies and Their Influence on the Intestinal Microbiome in Pediatric Inflammatory Bowel Disease
by Lara Hart, Charlotte M. Verburgt, Eytan Wine, Mary Zachos, Alisha Poppen, Mallory Chavannes, Johan Van Limbergen and Nikhil Pai
Nutrients 2022, 14(1), 4; https://doi.org/10.3390/nu14010004 - 21 Dec 2021
Cited by 14 | Viewed by 6543
Abstract
Inflammatory bowel disease (IBD) is a chronic, autoimmune disorder of the gastrointestinal tract with numerous genetic and environmental risk factors. Patients with Crohn’s disease (CD) or ulcerative colitis (UC) often demonstrate marked disruptions of their gut microbiome. The intestinal microbiota is strongly influenced [...] Read more.
Inflammatory bowel disease (IBD) is a chronic, autoimmune disorder of the gastrointestinal tract with numerous genetic and environmental risk factors. Patients with Crohn’s disease (CD) or ulcerative colitis (UC) often demonstrate marked disruptions of their gut microbiome. The intestinal microbiota is strongly influenced by diet. The association between the increasing incidence of IBD worldwide and increased consumption of a westernized diet suggests host nutrition may influence the progression or treatment of IBD via the microbiome. Several nutritional therapies have been studied for the treatment of CD and UC. While their mechanisms of action are only partially understood, existing studies do suggest that diet-driven changes in microbial composition and function underlie the diverse mechanisms of nutritional therapy. Despite existing therapies for IBD focusing heavily on immune suppression, nutrition is an important treatment option due to its superior safety profile, potentially low cost, and benefits for growth and development. These benefits are increasingly important to patients. In this review, we will describe the clinical efficacy of the different nutritional therapies that have been described for the treatment of CD and UC. We will also describe the effects of each nutritional therapy on the gut microbiome and summarize the strength of the literature with recommendations for the practicing clinician. Full article
Show Figures

Figure 1

23 pages, 1205 KiB  
Review
Therapeutic Potential of Various Plant-Based Fibers to Improve Energy Homeostasis via the Gut Microbiota
by Taylor M. Martinez, Rachel K. Meyer and Frank A. Duca
Nutrients 2021, 13(10), 3470; https://doi.org/10.3390/nu13103470 - 29 Sep 2021
Cited by 26 | Viewed by 5132
Abstract
Obesity is due in part to increased consumption of a Western diet that is low in dietary fiber. Conversely, an increase in fiber supplementation to a diet can have various beneficial effects on metabolic homeostasis including weight loss and reduced adiposity. Fibers are [...] Read more.
Obesity is due in part to increased consumption of a Western diet that is low in dietary fiber. Conversely, an increase in fiber supplementation to a diet can have various beneficial effects on metabolic homeostasis including weight loss and reduced adiposity. Fibers are extremely diverse in source and composition, such as high-amylose maize, β-glucan, wheat fiber, pectin, inulin-type fructans, and soluble corn fiber. Despite the heterogeneity of dietary fiber, most have been shown to play a role in alleviating obesity-related health issues, mainly by targeting and utilizing the properties of the gut microbiome. Reductions in body weight, adiposity, food intake, and markers of inflammation have all been reported with the consumption of various fibers, making them a promising treatment option for the obesity epidemic. This review will highlight the current findings on different plant-based fibers as a therapeutic dietary supplement to improve energy homeostasis via mechanisms of gut microbiota. Full article
Show Figures

Figure 1

28 pages, 8262 KiB  
Review
Citrulline, Biomarker of Enterocyte Functional Mass and Dietary Supplement. Metabolism, Transport, and Current Evidence for Clinical Use
by Stefano Maric, Tanja Restin, Julian Louis Muff, Simone Mafalda Camargo, Laura Chiara Guglielmetti, Stefan Gerhard Holland-Cunz, Pascal Crenn and Raphael Nicolas Vuille-dit-Bille
Nutrients 2021, 13(8), 2794; https://doi.org/10.3390/nu13082794 - 15 Aug 2021
Cited by 25 | Viewed by 7047
Abstract
L-Citrulline is a non-essential but still important amino acid that is released from enterocytes. Because plasma levels are reduced in case of impaired intestinal function, it has become a biomarker to monitor intestinal integrity. Moreover, oxidative stress induces protein citrullination, and antibodies against [...] Read more.
L-Citrulline is a non-essential but still important amino acid that is released from enterocytes. Because plasma levels are reduced in case of impaired intestinal function, it has become a biomarker to monitor intestinal integrity. Moreover, oxidative stress induces protein citrullination, and antibodies against anti-citrullinated proteins are useful to monitor rheumatoid diseases. Citrullinated histones, however, may even predict a worse outcome in cancer patients. Supplementation of citrulline is better tolerated compared to arginine and might be useful to slightly improve muscle strength or protein balance. The following article shall provide an overview of L-citrulline properties and functions, as well as the current evidence for its use as a biomarker or as a therapeutic supplement. Full article
Show Figures

Figure 1

Back to TopTop